Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure. | Transl Lung Cancer Res | 2022 | 36386463 | PubTator, text mining | PubMed |
| Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability. | PLoS Genet | 2022 | 36374936 | PubTator, text mining | PubMed |
| Biallelic PMS2 Mutations in a Family with Uncommon Clinical and Molecular Features. | Genes (Basel) | 2022 | 36360190 | PubTator, text mining | PubMed |
| Host Response of Human Epidermis to Methicillin-Resistant Staphylococcus aureus Biofilm Infection and Synthetic Antibiofilm Peptide Treatment. | Cells | 2022 | 36359854 | PubTator, text mining | PubMed |
| Classic and New Markers in Diagnostics and Classification of Breast Cancer. | Cancers (Basel) | 2022 | 36358862 | PubTator, text mining | PubMed |
| Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51. | Nat Commun | 2022 | 36344511 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
| Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service. | Sci Rep | 2022 | 36329109 | PubTator, text mining | PubMed |
| A moving target for drug discovery: Structure activity relationship and many genome (de)stabilizing functions of the RAD52 protein. | DNA Repair (Amst) | 2022 | 36327799 | PubTator, text mining | PubMed |
| Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. | Cell Death Dis | 2022 | 36307400 | PubTator, text mining | PubMed |
| Whole Exome Sequencing and In Silico Analysis of Human Sertoli in Patients with Non-Obstructive Azoospermia. | Int J Mol Sci | 2022 | 36293429 | PubTator, text mining | PubMed |
| Response of the Urothelial Carcinoma Cell Lines to Cisplatin. | Int J Mol Sci | 2022 | 36293346 | PubTator, text mining | PubMed |
| Repair Foci as Liquid Phase Separation: Evidence and Limitations. | Genes (Basel) | 2022 | 36292731 | PubTator, text mining | PubMed |
| Application of Multigene Panels Testing for Hereditary Cancer Syndromes. | Biology (Basel) | 2022 | 36290365 | PubTator, text mining | PubMed |
| Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma. | Biomed Res Int | 2022 | 36281462 | PubTator, text mining | PubMed |
| Construction and analysis of sample-specific driver modules for breast cancer. | BMC Genomics | 2022 | 36266635 | PubTator, text mining | PubMed |
| Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis. | PLoS One | 2022 | 36264998 | PubTator, text mining | PubMed |
| Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway. | Int J Mol Sci | 2022 | 36233090 | PubTator, text mining | PubMed |
| Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data. | Int J Mol Sci | 2022 | 36232764 | PubTator, text mining | PubMed |
| PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures. | Cancers (Basel) | 2022 | 36230674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=14